Table 3.
Metabolite | Chemical class |
Overall ES1 |
95% CI | Overall r |
Meta- analysis P value |
Pheterogeneity | PLCO ES |
Navy ES |
Shanghai ES |
PLCO P value |
Navy P value |
Shanghai P value |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Novel associations | ||||||||||||
3-(4-hydroxyphenyl) lactate | Amino acid | 0.86 | 0.58, 1.15 | 0.19 | 3.10*10−09 | 0.95 | 0.84 | 0.83 | 0.93 | 0.0001 | 0.0048 | 0.0007 |
Gamma-glutamyltyrosine | Peptide | 0.85 | 0.58, 1.12 | 0.19 | 6.27*10−10 | 0.83 | 0.83 | 0.74 | 0.96 | 6.03*10−05 | 0.0112 | 0.0001 |
Butyrylcarnitine | Lipid | 0.83 | 0.56, 1.09 | 0.20 | 9.95*10−10 | 0.91 | 0.87 | 0.84 | 0.74 | 1.36*10−05 | 0.0034 | 0.0024 |
2-hydroxybutyrate (AHB) | Amino acid | 0.82 | 0.55, 1.09 | 0.19 | 2.67*10−09 | 0.54 | 0.96 | 0.57 | 0.78 | 2.40*10−06 | 0.0601 | 0.0016 |
3-methyl-2-oxobutyrate | Amino acid | 0.76 | 0.49, 1.03 | 0.14 | 2.87*10−08 | 0.69 | 0.88 | 0.73 | 0.61 | 1.75*10−05 | 0.0115 | 0.0133 |
Gamma-glutamylisoleucine | Peptide | 0.73 | 0.39, 1.06 | 0.16 | 2.03*10−05 | 0.26 | 0.66 | 0.45 | 1.08 | 0.0021 | 0.1205 | 0.0001 |
7-HOCA2 | Lipid | 0.68 | 0.41, 0.95 | 0.16 | 9.66*10−07 | 0.41 | 0.88 | 0.51 | 0.51 | 2.26*10−05 | 0.0760 | 0.0394 |
Alpha-hydroxyisovalerate | Amino acid | 0.62 | 0.34, 0.90 | 0.14 | 1.19*10−05 | 0.49 | 0.46 | 0.65 | 0.87 | 0.0246 | 0.0273 | 0.0013 |
3-methyl-2-oxovalerate | Amino acid | 0.61 | 0.33, 0.89 | 0.14 | 1.68*10−05 | 0.57 | 0.51 | 0.50 | 0.83 | 0.0165 | 0.0847 | 0.0012 |
4-methyl-2-oxopentanoate | Amino acid | 0.57 | 0.29, 0.85 | 0.13 | 6.05*10−05 | 0.38 | 0.40 | 0.51 | 0.85 | 0.0659 | 0.0855 | 0.0008 |
3-hydroxyisobutyrate | Amino acid | 0.56 | 0.28, 0.83 | 0.13 | 6.88*10−05 | 0.52 | 0.65 | 0.27 | 0.64 | 0.0019 | 0.3636 | 0.0111 |
1-oleoylglycerophosphocholine | Lipid | −0.52 | −0.79, −0.25 | −0.13 | 0.00015 | 0.49 | −0.59 | −0.71 | −0.29 | 0.0039 | 0.0146 | 0.2517 |
1-eicosadienoylglycerophosphocholine | Lipid | −0.53 | −0.80, −0.27 | −0.13 | 9.56*10−05 | 0.51 | −0.65 | −0.62 | −0.30 | 0.0014 | 0.0296 | 0.2338 |
2-linoleoylglycerophosphocholine | Lipid | −0.61 | −0.88, −0.33 | −0.14 | 1.36*10−05 | 0.87 | −0.57 | −0.74 | −0.57 | 0.0066 | 0.0103 | 0.0255 |
Benzoate | Xenobiotics | −0.63 | −0.93, −0.33 | −0.15 | 3.41*10−05 | 0.31 | −0.86 | −0.54 | −0.38 | 3.06*10−05 | 0.0605 | 0.1384 |
N-acetylglycine | Amino acid | −0.67 | −0.94, −0.39 | −0.16 | 1.58*10−06 | 0.40 | −0.87 | −0.53 | −0.47 | 2.60*10−05 | 0.0731 | 0.0594 |
Palmitoyl sphingomyelin | Lipid | −0.70 | −0.99, −0.41 | −0.16 | 1.98*10−06 | 0.34 | −0.86 | −0.34 | −0.74 | 3.30*10−05 | 0.2397 | 0.0043 |
Histidine | Amino acid | −0.89 | −1.16, −0.63 | −0.21 | 7.61*10−11 | 0.57 | −1.05 | −0.79 | −0.74 | 2.85*10−07 | 0.0064 | 0.0034 |
Previously reported associations | ||||||||||||
Glutamate | Amino acid | 1.39 | 1.02, 1.77 | 0.33 | 2.51*10−13 | 0.14 | 1.70 | 1.33 | 1.09 | 5.09*10−16 | 2.36*10−06 | 8.03*10−06 |
Valine | Amino acid | 1.01 | 0.74, 1.28 | 0.25 | 4.17*10−13 | 0.35 | 0.78 | 1.10 | 1.22 | 0.0002 | 0.0001 | 4.16*10−07 |
Mannose | Carbohydrate | 0.95 | 0.56, 1.33 | 0.23 | 1.43*10−06 | 0.14 | 1.15 | 1.14 | 0.55 | 2.27*10−08 | 7.80*10−05 | 0.0266 |
Isoleucine | Amino acid | 0.93 | 0.65, 1.20 | 0.22 | 8.15*10−11 | 0.35 | 0.73 | 0.89 | 1.19 | 0.0006 | 0.0019 | 1.32*10−06 |
Isovalerylcarnitine | Amino acid | 0.93 | 0.60, 1.25 | 0.22 | 2.58*10−08 | 0.24 | 0.87 | 0.62 | 1.22 | 4.21*10−05 | 0.0320 | 5.09*10−07 |
Tyrosine | Amino acid | 0.91 | 0.65, 1.18 | 0.21 | 1.97*10−11 | 0.91 | 0.86 | 0.91 | 0.99 | 3.48*10−05 | 0.0014 | 5.12*10−05 |
Leucine | Amino acid | 0.88 | 0.51, 1.25 | 0.22 | 2.64*10−06 | 0.16 | 0.65 | 0.77 | 1.24 | 0.0019 | 0.0076 | 5.62*10−07 |
Andro steroid monosulfate 2 | Lipid | 0.82 | 0.54, 1.11 | 0.18 | 9.91*10−09 | 0.87 | 0.91 | 0.78 | 0.75 | 4.48*10−05 | 0.0103 | 0.0024 |
Lathosterol | Lipid | 0.78 | 0.51, 1.05 | 0.18 | 9.85*10−09 | 0.65 | 0.81 | 0.55 | 0.89 | 5.24*10−05 | 0.0545 | 0.0003 |
Kynurenine | Amino acid | 0.74 | 0.47, 1.01 | 0.17 | 9.42*10−08 | 0.65 | 0.82 | 0.50 | 0.79 | 6.51*10−05 | 0.0907 | 0.0016 |
Glycerol | Lipid | 0.67 | 0.38, 0.97 | 0.14 | 8.34*10−06 | 0.87 | 0.76 | 0.60 | 0.60 | 0.0009 | 0.0593 | 0.0212 |
Phenylalanine | Amino acid | 0.66 | 0.39, 0.93 | 0.16 | 1.30*10−06 | 0.65 | 0.57 | 0.89 | 0.63 | 0.0052 | 0.0019 | 0.0113 |
Hexanoylcarnitine | Lipid | 0.63 | 0.35, 0.91 | 0.14 | 8.53*10−06 | 0.77 | 0.67 | 0.45 | 0.71 | 0.0018 | 0.1216 | 0.0049 |
Propionylcarnitine | Lipid | 0.62 | 0.34, 0.89 | 0.14 | 1.22*10−05 | 0.77 | 0.70 | 0.45 | 0.62 | 0.0009 | 0.1295 | 0.0145 |
Carnitine | Lipid | 0.58 | 0.31, 0.85 | 0.13 | 2.76*10−05 | 0.82 | 0.48 | 0.68 | 0.63 | 0.0183 | 0.0176 | 0.0107 |
Lactate | Carbohydrate | 0.54 | 0.27, 0.82 | 0.12 | 0.00010 | 0.99 | 0.53 | 0.54 | 0.56 | 0.0125 | 0.0604 | 0.0231 |
1,5-AG3 | Carbohydrate | −0.69 | −0.96, −0.42 | −0.16 | 4.42*10−07 | 0.64 | −0.79 | −0.45 | −0.71 | 9.06*10−05 | 0.1239 | 0.0042 |
Asparagine | Amino acid | −0.80 | −1.10, −0.51 | −0.19 | 9.18*10−08 | 0.30 | −1.04 | −0.62 | −0.61 | 3.07*10−07 | 0.0310 | 0.0132 |
Glycine | Amino acid | −0.91 | −1.18, −0.61 | −0.21 | 2.53*10−11 | 0.89 | −0.91 | −0.80 | −0.98 | 8.02*10−06 | 0.0065 | 6.15*10−05 |
Results are based on a population of 947 participants (505 from PLCO, 258 from Navy, and 184 from Shanghai). Within each specific study, the association between metabolite levels and BMI was modeled using linear regression, adjusted for age, gender, current smoking status. PLCO models were additionally adjusted for study center and case status and Navy models were also adjusted for case status. The combined model was done using random effects meta-analysis. Only the metabolites that met the Bonferroni corrected threshold of statistical significance in the combined models, i.e. alpha=0.05/317=0.000158, are shown here. Complete results are shown in Table I of the online data supplement.
Effect Size (ES) indicates the increase in units of BMI (kg/m2) per one standard deviation increase in metabolite level (log-scale).
7–alpha–hydroxy–3–oxo–4–cholestenoate
1–5-anhydroglucitol